IRAP is also named oxytocinase since it was found to regulate the level of circulating oxytocin during the later stages of human pregnancy and, interestingly, is also highly expressed in brain regions associated with cognition, being recognized as a potential target for the treatment of cognitive disorders [33]. This evidence concerns the gene OXT and Cognitive impairment.